Bevers E M, Comfurius P, Nieuwenhuis H K, Levy-Toledano S, Enouf J, Belluci S, Caen J P, Zwaal R F
Br J Haematol. 1986 Jun;63(2):335-45. doi: 10.1111/j.1365-2141.1986.tb05557.x.
Prothrombinase activities of platelets have been measured in diluted platelet-rich plasma using a chromogenic substrate assay and purified coagulation factors. No abnormalities in prothrombinase activities were found for platelets from patients with storage pool disease (dense-body deficiency), grey platelet syndrome, and Glanzmann's thrombasthenia. It is concluded that neither release of dense bodies and alpha-granules nor aggregation of platelets are essential prerequisites for exposure of a procoagulant surface. Platelets from patients with Bernard-Soulier syndrome, however, have approximately 10-fold higher prothrombinase activities in the non-stimulated form than normal non-stimulated platelets. The increased procoagulant activity cannot be completely ascribed to an increase in platelet size. It is suggested that the increased prothrombinase activity reflects an increased exposure of phosphatidylserine at the outer surface of non-stimulated Bernard-Soulier platelets, earlier described by Perret et al (1983).
已使用发色底物测定法和纯化的凝血因子,在稀释的富含血小板血浆中测量了血小板的凝血酶原酶活性。对于患有储存池病(致密体缺乏症)、灰色血小板综合征和Glanzmann血小板无力症的患者的血小板,未发现凝血酶原酶活性异常。结论是,致密体和α-颗粒的释放以及血小板的聚集都不是暴露促凝表面的必要先决条件。然而,患有Bernard-Soulier综合征的患者的血小板,在非刺激形式下的凝血酶原酶活性比正常非刺激血小板高约10倍。凝血活性的增加不能完全归因于血小板大小的增加。有人提出,凝血酶原酶活性的增加反映了非刺激的Bernard-Soulier血小板外表面磷脂酰丝氨酸的暴露增加,这一点Perret等人(1983年)曾较早描述过。